An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.
Erciyes University, Kayseri, Turkey
Gachon University Gil Medical Cneter, Incheon, Korea, Republic of
Nationwide Children's Hospital, Columbus, Ohio, United States
Texas Children's Hospital, Houston, Texas, United States
Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Boston Children's Hospital, Boston, Massachusetts, United States
School and Hospital of Stomatology, Beijing, Beijing, China
NYU Langone Medical Center, New York, New York, United States
University Hospital, University of Sao Paulo, Sao Paulo, SP, Brazil
Fujian Provincial Hospital, Fuzhou, Fujian, China
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.